This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Genevieve Perry: Innovator in Pharmaceutical Science
Introduction
Genevieve Perry is a notable inventor based in Toulouse, France. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. Her work has the potential to impact the treatment of various medical conditions.
Latest Patents
Genevieve Perry holds a patent for "Drugs containing a glycosylated interleukin-2." This patent describes an interleukin-2 preparation suitable for pharmaceutical purposes. The preparation consists essentially of disialilated glycosylated interleukin-2, monosialilated glycosylated interleukin-2, or a mixture thereof, and is substantially free of organic solvents. It is isolated from recombinant CHO cells transformed with a vector containing a DNA sequence coding for a natural precursor of human interleukin-2, and is purified by a multi-step process. She has 1 patent to her name.
Career Highlights
Genevieve Perry is associated with Sanofi, a leading global healthcare company. Her role at Sanofi has allowed her to work on groundbreaking research and development projects. Her contributions have been instrumental in advancing the company's pharmaceutical offerings.
Collaborations
Genevieve has collaborated with notable colleagues, including Alain Bayol and Willem Roskam, who have contributed to her research endeavors. Their combined expertise has fostered a productive environment for innovation.
Conclusion
Genevieve Perry's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patent on glycosylated interleukin-2 showcases her commitment to advancing medical science. Through her career at Sanofi and collaborations with esteemed colleagues, she continues to make a significant impact in her field.